Exploring Elfun Trusts (Trades, Portfolio)' Strategic Moves in Q1 2025

Warning! GuruFocus has detected 3 Warning Sign with MSFT.

Elfun Trusts (Trades, Portfolio) recently submitted its N-PORT filing for the first quarter of 2025, revealing strategic investment decisions made during this period. Elfun Trusts (Trades, Portfolio) is a fund exclusively available to General Electric's U.S. employees and trustees, forming part of the Elfun Funds alongside the Elfun International Equity Fund. Initially managed by David Carlson until 2019, the fund is now under the stewardship of William Sandow and Christopher Sierakowski. The fund's investment strategy focuses on U.S. companies, selecting equity securities from various industries based on individual company merits. The portfolio manager also considers companies with potential future dividend payouts, emphasizing stock selection as a key performance driver.Elfun Trusts Exits UnitedHealth Group Inc, Impacting Portfolio by -1.79%

Summary of New Buy

Elfun Trusts (Trades, Portfolio) added a total of three stocks to its portfolio, with the most significant addition being Uber Technologies Inc (NYSE:UBER). The fund acquired 856,000 shares, representing 1.6% of the portfolio, with a total value of $62.37 million. The second-largest addition was Eli Lilly and Co (NYSE:LLY), with 67,800 shares, accounting for approximately 1.44% of the portfolio and valued at $55.99 million. The third-largest addition was The Goldman Sachs Group Inc (NYSE:GS), with 83,300 shares, making up 1.17% of the portfolio and valued at $45.51 million.

Key Position Increases

Elfun Trusts (Trades, Portfolio) increased its stakes in eight stocks, with the most notable increase in Eaton Corp PLC (NYSE:ETN). The fund added 77,700 shares, bringing the total to 233,000 shares, marking a significant 50.03% increase in share count and a 0.54% impact on the current portfolio, with a total value of $63.34 million. The second-largest increase was in Synopsys Inc (NASDAQ:SNPS), with an additional 27,700 shares, bringing the total to 107,500 shares, representing a 34.71% increase in share count and valued at $46.10 million.

Summary of Sold Out

Elfun Trusts (Trades, Portfolio) completely exited four holdings in the first quarter of 2025. The most impactful sale was UnitedHealth Group Inc (NYSE:UNH), with the fund selling all 149,956 shares, resulting in a -1.79% impact on the portfolio. Another significant exit was Ulta Beauty Inc (NASDAQ:ULTA), with the liquidation of all 119,800 shares, causing a -1.23% impact on the portfolio.

Key Position Reduces

Elfun Trusts (Trades, Portfolio) reduced its position in 12 stocks, with the most significant changes including a reduction in Mastercard Inc (NYSE:MA) by 83,100 shares, resulting in a -54.46% decrease in shares and a -1.03% impact on the portfolio. The stock traded at an average price of $544.39 during the quarter, returning 1.64% over the past three months and 7.77% year-to-date. Another notable reduction was in JPMorgan Chase & Co (NYSE:JPM), with a decrease of 104,200 shares, resulting in a -19.19% reduction in shares and a -0.59% impact on the portfolio. The stock traded at an average price of $254.94 during the quarter, with a return of -0.84% over the past three months and 9.87% year-to-date.

Story Continues

Portfolio Overview

As of the first quarter of 2025, Elfun Trusts (Trades, Portfolio)' portfolio comprised 43 stocks. The top holdings included 8.04% in Microsoft Corp (NASDAQ:MSFT), 7.58% in NVIDIA Corp (NASDAQ:NVDA), 6.73% in Apple Inc (NASDAQ:AAPL), 5.49% in Amazon.com Inc (NASDAQ:AMZN), and 4.51% in Meta Platforms Inc (NASDAQ:META). The holdings are primarily concentrated in 11 industries: Technology, Financial Services, Healthcare, Communication Services, Industrials, Consumer Cyclical, Energy, Utilities, Basic Materials, Real Estate, and Consumer Defensive.Elfun Trusts Exits UnitedHealth Group Inc, Impacting Portfolio by -1.79%

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.

View Comments